Insulet Corporation provided revenue guidance for the quarter ending December 31, 2022. For the quarter ending December 31, 2022, the company expects revenue growth of 11% to 14%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
181.9 USD | -1.22% | +5.46% | -16.27% |
May. 14 | Insulet Shares Rise Despite Blue Orca's Short Position | MT |
May. 10 | Raymond James Adjusts Price Target on Insulet to $213 From $218 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.27% | 12.9B | |
-6.80% | 180B | |
+3.22% | 112B | |
-3.66% | 68.53B | |
+5.45% | 51.97B | |
+5.73% | 44.08B | |
+5.62% | 42.23B | |
+24.30% | 32.43B | |
+16.72% | 26.39B | |
-3.72% | 24.97B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Insulet Corporation Provides Revenue Guidance for the Quarter Ending December 31, 2022